EatingWell on MSN5d
Simple 7-Day GLP-1-Friendly Meal Plan for Beginners, Created by a Dietitian
Recipe photos: Morgan Hunt Glaze and Jen Causey. EatingWell design.
ConsumerAffairs6d
Hims & Hers withdraws from Wegovy, Ozempic market
Hims & Hers is stopping its sales of an alternative to blockbuster weight-loss drugs Wegovy and Ozempic. That follows the U.S ...
News on 619h
FDA ends shortage of popular weight-loss drugs like Ozempic and Wegovy
The FDA has declared that the shortage of popular weight-loss drugs, including Ozempic and Wegovy, is officially over.
CNN10d
Ozempic and Wegovy are no longer in shortage, FDA says
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in ... but the FDA said that they do not plan to take any action against compounding pharmacies for 60 to 90 days.
Patients struggle with lack of consistent coverage for popular weight-loss drugs
Many employers and insurers are scaling back coverage of Wegovy and Zepbound and a key government program, Medicare, doesn’t ...
The Baltimore Sun10d
Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says
Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the popular diabetes and obesity treatments continue to improve, federal ...
HeraldNet13d
Wegovy®, Ozempic®, and Mounjaro®—Here’s How I Got My Prescription Through MEDVi
MEDVi is a telehealth platform designed to provide personalized weight loss solutions through FDA-approved GLP-1 medications such as Semaglutide (Ozempic®, Wegovy®) and Tirzepatide (Mounjaro®).